Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 125 M144 M129 M124 M130 M138 M 521 M Research & development —————— — Operating income 65 M-263 M64 M21 M53 M102 M 240 M Non-Operating Income, Total -15 M1 M4 M-5 M5 M-7 M -3 M Interest expense, net of interest capitalized 52 M32 M53 M46 M53 M42 M 194 M Non-Operating Income, excl. Interest Expenses -67 M-31 M-49 M-51 M-48 M-49 M -197 M Unusual income/expense —————— — Pretax income 47 M-265 M66 M64 M41 M76 M 247 M Equity in earnings 25 M18 M17 M8 M27 M13 M 65 M Taxes 22 M48 M7 M26 M42 M32 M 107 M Non-controlling/minority interest 25 M22 M23 M20 M21 M17 M 81 M After tax other income/expense 3 M-5 M5 M12 M-2 M-1 M 14 M Net income before discontinued operations 0-335 M36 M18 M-22 M27 M 59 M Discontinued operations —————— — Net income 0-335 M36 M18 M-22 M27 M 59 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 0-335 M36 M18 M-22 M27 M 59 M Basic earnings per share (Basic EPS) 0-3.990.430.17-0.280.34 0.66 Diluted earnings per share (Diluted EPS) 0-3.990.430.17-0.280.34 0.66 Average basic shares outstanding 84.4 M84 M83.5 M83 M78.7 M78.4 M — Diluted shares outstanding 84.7 M84 M83.7 M83 M78.7 M79.3 M — EBITDA 194 M-127 M122 M92 M89 M138 M 441 M EBIT 20 M-311 M13 M-28 M5 M54 M 44 M Cost of revenue 3.28 B3.35 B3.5 B3.44 B3.43 B3.61 B 13.98 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 84 M97 M109 M120 M84 M84 M 397 M